Innovax specializes in developing advanced vaccine solutions aimed at enhancing the health and productivity of poultry flocks. Their innovative approach includes the creation of the Innovax-ND-IBD vaccine, which is the first dual-construct HVT vaccine designed to provide protection against three significant poultry diseases: Infectious Bursal Disease (IBD), Newcastle Disease (ND), and Marek’s Disease (MD). This unique 3-in-1 vaccine offers long-term immunity in a single, non-reactive dose, addressing the challenges posed by traditional vaccination methods that can induce adverse reactions or negatively impact bird performance.

In addition to their vaccine offerings, Innovax emphasizes the importance of disease risk analysis and early intervention through their Convenience Program. This program is designed to optimize vaccine protection and improve overall flock health and productivity. By focusing on rigorous research and development, Innovax aims to deliver superior, long-term disease protection, ultimately contributing to the profitability and efficiency of poultry operations. Their commitment to innovation in vaccine technology positions them as a key player in the poultry health sector.

China

Innovax delivers superior, long-term disease protection against infectious poultry diseases. Through rigorous research and development, it develops new ways to optimize flock protection and increase production efficiency with breakthrough vaccinations.

Innovax

Company Details